Development of Antivirals, (Funder By Kagoshima University, Japan), 2016- Continue (33 Lacs received)
- Project Status: Ongoing
Structure Based Discovery of novel antiviral molecules with potential to inhibit drug resistance viruses. (PI); Multi-Institutional Project (BIT-NCCS-ICMR) DBT BT/PR14237/MED/29/196/2010; OCT, 2010 2010-2014; 25.00 Lacs.
- Project Status: Ongoing
The target based discovery of carbocyclic nucleosides as an anti-HCV agent through computer assisted drug design and synthesis. (PI); SERB-DST SR/FT/CS-001/2009; Sep 07, 2009; 2009-2013; 17.03 Lacs.
- Project Status: Ongoing
Deciphering the mode of antiviral action of isolated phytoconstituents and their synthetic analogues/counterparts combining structure and analogs-based approach to develop a therapeutic anti-viral candidate. (PI) Multi-Institutional Project (BIT- ICMR); D
- Project Status: Ongoing
Synthesis and development of novel HSP90 inhibitors as potential anti-HIV candidate molecules and elucidation of their mechanism of inhibition. SERB-DST, DEC 2018 - DEC 2021. (25 Lacs)
- Project Status: Ongoing
Computer assisted design and synthesis of carbocyclic nucleosides as an anti-hepatitis agent. (PI) UGC, F.No.37-110/2009 (SR); Dec 19, 2009; 2010-2013; 5.94 Lacs.
- Project Status: Ongoing